Single-centre retrospective analysis of growth hormone supplementation in IVF patients classified as poor-prognosis.
Kevin N KeaneJohn L YovichAnahita HamidiPeter M HinchliffeSatvinder S DhaliwalPublished in: BMJ open (2017)
These data provided further evidence to indicate that GH may support more live births, particularly in younger women. It also appears that embryos generated under GH have a better implantation potential, but whether the biological mechanism is embryo-mediated or endometrium-mediated is unclear.
Keyphrases
- growth hormone
- poor prognosis
- end stage renal disease
- long non coding rna
- pregnancy outcomes
- newly diagnosed
- ejection fraction
- chronic kidney disease
- peritoneal dialysis
- prognostic factors
- polycystic ovary syndrome
- type diabetes
- electronic health record
- patient reported outcomes
- machine learning
- adipose tissue
- skeletal muscle
- metabolic syndrome
- insulin resistance
- patient reported